We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current USNA market cap is 467.7M. The company's latest EPS is USD 2.2233 and P/E is 11.12.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 221.08M | 227.8M | 212.87M | 200.22M | 213.61M |
| Operating Income | 24.22M | 24.67M | 17.84M | 15.6M | 8.21M |
| Net Income | 16.77M | 16.54M | 10.43M | 10.61M | 4.45M |
| Year End 28 December 2024 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.13B | 1.19B | 998.6M | 921.01M | 854.5M |
| Operating Income | 176.49M | 170.19M | 107.61M | 93.07M | 66.32M |
| Net Income | 124.66M | 116.51M | 69.35M | 63.79M | 42.03M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 632.76M | 629.28M | 631.42M | 671.31M | 748.19M |
| Total Liabilities | 135.56M | 129.29M | 119.21M | 138.22M | 161.86M |
| Total Equity | 497.2M | 499.99M | 512.21M | 533.09M | 532.11M |
| Year End 28 December 2024 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 640.89M | 577.74M | 596.55M | 632.76M | 748.19M |
| Total Liabilities | 199.24M | 182.62M | 162.08M | 135.56M | 161.86M |
| Total Equity | 441.65M | 395.12M | 434.47M | 497.2M | 532.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 70.64M | 17.68M | 25.67M | 55.21M | 60.99M |
| Investing | -11.98M | -4.07M | -5.61M | -7.95M | -213.09M |
| Financing | -14.24M | -11.95M | -13.3M | -13.38M | 9.55M |
| Year End 28 December 2024 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 160.4M | 121.23M | 103.9M | 70.64M | 60.99M |
| Investing | -33.96M | -14.19M | -12.37M | -11.98M | -213.09M |
| Financing | -59.44M | -181.41M | -30.09M | -14.24M | 9.55M |
| Market Cap | 467.7M |
| Price to Earnings Ratio | 11.12 |
| Price to Sales Ratio | 0.55 |
| Price to Cash Ratio | 2.57 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 18.9M |
| Average Volume (1 week) | 252.53k |
| Average Volume (1 Month) | 212.31k |
| 52 Week Change | -46.15% |
| 52 Week High | 49.78 |
| 52 Week Low | 23.67 |
| Spread (Intraday) | 4.68 (16.6%) |
| Company Name | USANA Health Sciences |
| Address |
15 west south temple salt lake city, utah 84101 |
| Website | https://www.usana.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
